Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
113 Ergebnisse für "hyperplasia" unter Somagenetix
Long-term outcome of primary bilateral macronodular adrenocortical ...
... bilateral macronodular adrenocortical hyperplasia (PBMAH), but its long-term outcome is unclear. OBJECTIVE ... patients with primary bilateral macronodular adrenocortical hyperplasia (PBMAH), but its long-term outcome ... Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral ... Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral ... Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral ...
Glucagon cell hyperplasia and neoplasia with and without glucagon r...
... the GCGR signaling pathways GCGR mutations probably cause GCA via glucagon cell hyperplasia. GCA also ... the GCGR signaling pathways GCGR mutations probably cause GCA via glucagon cell hyperplasia. GCA also ... Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations - Zurich Open ... Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations - Zurich Open ... Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations - Zurich Open ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
49 Ergebnisse für "hyperplasia" unter University of Zurich
Visualization of parathyroid hyperplasia using 18F-fluorocholine PE...
... patients with primary hyperparathyroidism. Unlike solitary parathyroid adenoma, parathyroid hyperplasia in ... imaging tool suitable for the diagnosis and presurgical assessment of parathyroid hyperplasia. Abstract ... Visualization of parathyroid hyperplasia using 18F-fluorocholine PET/MR in a patient with secondary ... Visualization of parathyroid hyperplasia using 18F-fluorocholine PET/MR in a patient with secondary ... Visualization of parathyroid hyperplasia using 18F-fluorocholine PET/MR in a patient with secondary ...
Differential patterns of Large Tumor Antigen specific immune respon...
... patients with BK polyomavirus positive prostate cancer or benign prostatic hyperplasia Sais, Giovanni ... prostate cancer or benign prostatic hyperplasia. Journal of Virology, 86(16):8461-8471. Copy Abstract The ... polyomavirus positive prostate cancer or benign prostatic hyperplasia - Zurich Open Repository and Archive ... positive prostate cancer or benign prostatic hyperplasia Sais, Giovanni ; Wyler, Stephen ; Hudolin, Tvrtko ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
52 Ergebnisse für "hyperplasia" unter University Hospital Zurich, Research and Education Office
Slide O 17
... zystische lymphoide Hyperplasie der Parotis cystic lymphoid hyperplasia ... of parotid gland HE cystic lymphoid hyperplasia of parotid gland O 17 50-jähriger ... Slide O 17 zystische lymphoide Hyperplasie der Parotis cystic lymphoid hyperplasia of parotid ... gland HE cystic lymphoid hyperplasia of parotid gland O 17 50-jähriger Patient, HIV positiv, zystischer ...
Slide A III 2
... maintained, the zona glomerulosa, fasciculata and reticularis can readily be distinguished. - In hyperplasia ... larger than usual (hypertrophy) and the absolute number of cells is increased ( hyperplasia). Pathogenesis ... Slide A III 2 Hyperplasie der Nebennierenrinde adrenocortical hyperplasia HE adrenocortical ... hyperplasia ICD-10: E27.0 A III 2 Mann, 79 J., metastasierendes Kolonkarzinom. Autopsiepräparat ...
Qvanteq AG
8005 Zürich, Technoparkstrasse 1 / Transfer Nord 2021
+41 44 500 98 90
info@qvanteq.com
Development and manufacturing of bioactive vascular stents to restore flow in diseased blood vessels.
Qvanteq AG
Technoparkstrasse 1
8005 Zürich
3 Ergebnisse für "hyperplasia" unter Qvanteq AG
Qstent – Qvanteq
... reduced neointimal hyperplasia and improved endothelialization compared to commercially available and ... combinations. Animal studies conducted by CBSET ( www.cbset.org ) showed reduced neointimal hyperplasia and ...
Mechanism of Action – Qvanteq
... as: low thrombogenicity, increased speed of endothelialization and reduced neointimal hyperplasia. ... endothelialization and reduced neointimal hyperplasia. Recent News Qvanteq ISO13485:2016 re-certification In ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
1 Ergebnisse für "hyperplasia" unter Bio-Technopark Schlieren-Zürich
Proteomedix acquired by Blue Water Biotech to form Onconetix Inc., ...
... products for the diagnosis of prostate cancer and the treatment and benign prostate hyperplasia. Under the ... treatment of benign prostatic hyperplasia (BPH), and Proclarix®, a European CE IVD approved prostate ... prostate cancer and the treatment and benign prostate hyperplasia. Under the terms of the agreement ... hyperplasia (BPH), and Proclarix ® , a European CE IVD approved prostate diagnostics and a lab developed test ...
ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
6 Ergebnisse für "hyperplasia" unter ETH Zürich - Numerische Materialmodellierung
Research – Institute of Biochemistry | ETH Zurich
... Research Nutrient restriction (NR) causes a shift from hypertrophy to hyperplasia in PTEN mutant ... ) causes a shift from hypertrophy to hyperplasia in PTEN mutant cells Tumor cells evade the breaks imposed ...
Research – Laboratory of Translational Nutrition Biology | ETH Zurich
... is achieved through hypertrophy and hyperplasia. Whereas adipocyte hypertrophy (increase in size) is ... strongly associated with insulin resistance and local tissue inflammation, hyperplasia (increase in number ... is achieved through hypertrophy and hyperplasia. Whereas adipocyte hypertrophy (increase in size) is ... strongly associated with insulin resistance and local tissue inflammation, hyperplasia (increase in number ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
4 Ergebnisse für "hyperplasia" unter Roche Glycart AG
AVENIO Millisect System - Roche Sequencing Solutions
... , exportable as a PDF Pre-and post-dissection image capture Kader, T. et al. Atypical ductal hyperplasia is a ... . Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma. J Pathol. 2019 Jul;248(3):326 ...
AVENIO Millisect System
... Brochure Publications Kader, T. et al. Atypical ductal hyperplasia is a multipotent precursor of breast ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1 Ergebnisse für "hyperplasia" unter ETH Entrepreneurship
1
... Increased incidence of spleen tumors, hyperplasia in the spleen, increased spleen weights, hemolytic anemia ... ) Decreased body weights, increased relative liver weights, stomach hyperplasia, and benign stomach tumors ... Increased incidence of spleen tumors, hyperplasia in the spleen, increased spleen weights, hemolytic anemia ... ) Decreased body weights, increased relative liver weights, stomach hyperplasia, and benign stomach tumors ...